Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Companies / Bioprojet Europe
Entity

Bioprojet Europe

Tracked across 1 events · 6 articles · First seen Aug 17, 2026 · Last active Aug 17, 2026

Sentiment
-20
Attention
2
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (1)
2 -20
Regulatory
Lupin FDA Approval Pitolisant Tablets
Lupin (company) announced on August 17, 2026, that it received final approval from the U.S. United States — Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Pitolisant Tablets, 4.45 mg…
Impact: Bioprojet Europe is the holder of the Wakix trademark; the approval of a generic version may erode its market share and pricing power for the brand product.
Aug 17, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Bioprojet Europe live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.